Monitor the next quarterly earnings call for any strategic shifts under the new CEO, but this filing itself contains no actionable trading signal.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 1 $45.23entry
- T+1 · 5w ago +1.08%α +0.34% · $45.72
- T+5 · 28d ago −2.41%α −3.71% · $44.14
- T+20 · 7d ago +3.56%α +2.86% · $46.84
- T+24 · todayOpen
- T+60 · in 8w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Omega Healthcare Investors announced the planned CEO succession: President Matthew P. Gourmand was appointed President and CEO effective October 1, 2026, succeeding C. Taylor Pickett upon his retirement. Gourmand also joined the board. The retirement is stated as not resulting from any disagreement. This is a routine, pre-disclosed leadership transition with no financial or operational surprises.
Key Facts
- Matthew P. Gourmand appointed President and CEO effective October 1, 2026, succeeding retiring CEO C. Taylor Pickett.
- Gourmand also appointed to the board to fill Pickett's vacancy, term expiring 2027.
- Pickett's retirement is not due to any disagreement with the company.
- Board size remains at eight; Gourmand not expected to join any board committees.
- Gourmand has been President since January 2025 and previously held senior IR and strategy roles at Omega.
Financial Impact
No financial impact disclosed; routine CEO succession.
Risk Factors
- Potential strategic pivot under new leadership could introduce uncertainty.
- No material risk from this routine succession filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-112589 |
| Document: 0001104659-26-112589-index-headers.html | 0001104659-26-112589 |
| Document: 0001104659-26-112589-index.html | 0001104659-26-112589 |
| Document: 0001104659-26-112589.txt | 0001104659-26-112589 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 1d ago | 8-K | $47.53 | awaiting T+5 | awaiting T+5 | $47.53 (−0.00%) |
Oct 27, 2026 8d ago | Institutional Cluster | $45.64 $49.17 | ▲ +7.73% | ▲ +8.45% | $47.53 (+4.14%) |
Oct 27, 2026 8d ago | SC 13G/A | $45.64 $49.17 | ▲ +7.73% | ▲ +8.45% | $47.53 (+4.14%) |
Oct 16, 2026 19d ago | Institutional Cluster | $45.64 $46.23 | ▲ +1.29% | ▲ +1.72% | $47.53 (+4.14%) |
Oct 5, 2026 4w ago | 8-K | $45.36 $45.17 | ▼ −0.42% | ▼ −0.84% | $47.53 (+4.78%) |
Oct 1, 2026 4w ago | 8-K | $45.23 $44.14 | ▼ −2.41% | ▼ −3.71% | $47.53 (+5.09%) |
Apr 21, 2026 28w ago | DEFA14A | $45.81 $47.42 | ▲ +3.51% | ▲ +2.43% | $47.53 (+3.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers